Professor Dr. Friedemann Kiefer

Job TitleFriedemann kiefer (2)

Group Leader Mammalian Cell Signaling Laboratory

Address

Max Planck Institute for Molecular Biomedicine, Münster

Biography

1) General information

Kiefer, Friedemann, Dr. rer nat, 15.02.1961, male
Max Planck Institute for Molecular Biomedicine, Röntgenstr. 20, 48149 Münster Phone: 0251 703 65 230; email: fkiefer@gwdg.de
Research group leader, Professor for Intravital Molecular Imaging

2) Academic education
Biochemistry (10/1981 – 06/1988), University of Tübingen, Diplom, Prof. Dr. Dieter Gallwitz

3) Scientific degrees
Habilitation: Venia Legendi in Cell Biology, Faculty of Medicine, University of Marburg, 2001, Prof. Dr. Roland Lill
Promotion: Biology, University of Tübingen, 1993, Dr. Erwin Wagner, Dr. Werner Risau

4) Professional career
Starting 2017 Professor for Intravital Molecular Imaging (W3) at the European Institute for Molecular Imaging, University of Münster, Münster
10/2007 – present Reseach group leader (W2), Max Planck Institute, Münster 04/2006 – present Head of Transgenic Services, Max Planck Institute, Münster 07/2002 – 09/2007 Group leader, Dept. Vasc. Cell Biol., Max Planck Institute,
Münster
08/1988 – 06/2002 PI, Dept. Mol. Cell Biol., Max Planck Institute for
Physiological and Clinical Research, Bad Nauheim 07/1996 – 07/1998 Postdoctoral fellow, Samuel Lunenfeld Research Institute,
Toronto, Canada, Prof. Dr. Tony Pawson
05/1993 – 06/1996 Postdoctoral fellow. Ontario Cancer Institute, Toronto, Canada, Prof. Dr. Norman N. Iscove, DFG fellowship

5) Miscellaneous
Since 2016 Editorial board member Mol. and Cell. Biology Since 2013 Member of the board SFB 656
Since 2010 Adjunct. Professor, University of Münster, Faculty of Medicine,
Germany
Since 2006 Member of the Faculty of 1000, division of cell biology 2006 – 2008 Secretary of the German Society for Cell Biology (DGZ)

Platform Statement

It is with great pleasure that I confirm my interest in an active participation in the European Vascular Biology Organisation, EVBO. Over the last 25 years since the identification of Flk1 as a receptor for VEGF‐A, European vascular biologists have contributed steadily and significantly to the success of the thriving field of vascular biology. At the same time, vascular biology has matured from a multidisciplinary into an interdisciplinary field that requires and deserves a common European platform for this highly active and diverse research and clinical community. I truly believe that the EVBO provides such a platform and deserves active support and endorsement. Therefore, I would be most delighted to personally support the aims and work of the EVBO.

Web Address

http://www.mpi-muenster.mpg.de/104590/kiefer